Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCAREPVTLTDADA8 65b0b7e3912bef38d51b547d Medicines https://www.sterispharma.com
{ "products": [ { "_id": "67e29c5bd304df5a97e70101", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH 10", "description": "EMPATECH 10 contains Empagliflozin (10mg), a highly effective oral medication used for the management of type 2 diabetes mellitus. It helps regulate blood sugar levels by promoting glucose excretion through urine, reducing the risk of complications like heart disease and kidney damage. With its unique action, EMPATECH 10 not only aids in diabetes control but also supports overall cardiovascular and renal health.\n\n \nKey Benefits:\n\nEffective Blood Sugar Control – Lowers blood glucose levels and improves diabetes management.\nSupports Weight Management – Aids in weight loss by eliminating excess glucose.\nReduces Risk of Cardiovascular Diseases – Helps protect the heart and lower the risk of heart failure.\nPromotes Kidney Health – Prevents diabetic kidney damage by reducing strain on the kidneys.\nLowers Blood Pressure – Has a mild diuretic effect, which helps in managing hypertension.\n\n \nHow Does It Work?\n \n\nEmpagliflozin works by inhibiting the SGLT2 protein in the kidneys, preventing glucose reabsorption into the bloodstream. This results in excess glucose being excreted through urine, thereby lowering blood sugar levels naturally. Unlike insulin-based treatments, it works independently of insulin secretion, making it a beneficial option for many patients.\n\n \nDirections for Use:\n \n\nTake EMPATECH 10 exactly as prescribed by your doctor.\n\nSwallow the tablet whole with water, preferably once daily in the morning.\n\nIt can be taken with or without food.\n\nMaintain a healthy diet and exercise routine for best results.\n\nDo not stop the medication without consulting your healthcare provider.\n\n \nSide Effects:\n\nWhile EMPATECH 10 is generally well-tolerated, some individuals may experience:\n\nFrequent Urination\nIncreased Thirst\nUrinary Tract Infections (UTIs)\nDizziness or Low Blood Pressure\nGenital Infections (in some cases)\n\nIf you experience severe dehydration, allergic reactions, or persistent infections, seek medical help immediately.", "price": 135.0, "discountamount": 41.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1400, "imageuri": "https://bizimages.withfloats.com/actual/6d186117600942b8b72630e161b2804e.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/6d186117600942b8b72630e161b2804e.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-25T12:06:51.305Z", "updatedon": "2025-03-26T12:05:39.986Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/empatech-10/1400", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin 10 mg", "category": "Diabetic Range", "tags": [ "Empagliflozin 10mg", "Empagliflozin 10mg uses", "empagliflozin 10 mg​ brands in india", "empagliflozin 10 mg tablet​", "empagliflozin 10 mg price​", "empagliflozin jardiance 10 mg​" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67e298ff84075b7fd68a275c", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN SITA 25/100", "description": "GLIEMPAFLOZIN SITA 25/100 is an advanced anti-diabetic medication containing Empagliflozin (25mg) and Sitagliptin (100mg), formulated to effectively control blood sugar levels in individuals with Type 2 Diabetes Mellitus. This powerful combination helps regulate glucose levels, improve insulin function, and reduce the risk of diabetes-related complications. It is designed for patients requiring dual therapy to achieve better glycemic control.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control – Lowers HbA1c levels and maintains long-term glycemic stability.\nPromotes Weight Loss – Empagliflozin helps in reducing excess body weight by eliminating excess glucose.\nHeart & Kidney Protection – Reduces the risk of cardiovascular diseases and kidney complications.\nEnhanced Insulin Sensitivity – Improves insulin response and minimizes glucose spikes.\nConvenient Dual Therapy – Combines two powerful anti-diabetic agents in one tablet for better diabetes management.\n\n \nHow Does It Work?\n \n\nEmpagliflozin blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting glucose excretion through urine. This helps lower blood sugar levels naturally while supporting heart and kidney health.\n\nSitagliptin works by inhibiting the DPP-4 enzyme, which increases the levels of incretin hormones that stimulate insulin release and reduce glucose production in the liver.\n\nTogether, they offer comprehensive diabetes control by lowering blood sugar through different mechanisms, making it a superior option for Type 2 Diabetes management.\n\n \nDirections for Use:\n \n\nTake GLIEMPAFLOZIN SITA 25/100 as prescribed by your doctor.\n\nSwallow the tablet whole with water, preferably once daily with or without food.\n\nMaintain a healthy diet and regular exercise for best results.\n\nDo not exceed the recommended dosage without consulting a healthcare professional.\n\n \nSide Effects:\n \n\nWhile generally well-tolerated, some users may experience:\n\nFrequent Urination (due to glucose excretion)\nDehydration & Dizziness\nMild Nausea or Stomach Discomfort\nHypoglycemia (Low Blood Sugar) – Especially if combined with insulin or sulfonylureas\nUrinary or Genital Infections (due to increased sugar excretion in urine)\n\nSeek medical attention if you experience severe allergic reactions, persistent dizziness, or signs of dehydration.", "price": 425.0, "discountamount": 128.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "sulfonylureas urinary", "generally welltolerated", "recommended dosage", "regular exercise", "healthy diet", "food maintain", "water preferably", "doctor swallow", "gliempaflozin sita 25100", "superior option", "mechanisms making", "incretin hormones", "dpp4 enzyme", "supporting heart", "sglt2 protein", "diabetes management", "cardiovascular diseases", "diabetesrelated complications", "empagliflozin 25mg", "reduce glucose production", "stimulate insulin release", "work empagliflozin blocks", "increased sugar excretion", "genital infections due", "lowering blood sugar", "promoting glucose excretion", "powerful antidiabetic agents", "sitagliptin 100mg formulated", "advanced antidiabetic medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1397, "imageuri": "https://bizimages.withfloats.com/actual/5eea78523d4740a092e22644d2f108be.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/5eea78523d4740a092e22644d2f108be.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-25T11:52:31.562Z", "updatedon": "2025-03-25T11:53:30.264Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/gliempaflozin-sita-25-100/1397", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin 25mg, Sitagliptin 100mg", "category": "Diabetic Range", "tags": [ "Empagliflozin 25mg,", "Sitagliptin 100mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67a20c5e0d008ab27602b2a5", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN MET 12.5mg/ 500mg ", "description": "GLIEMPAFLOZIN MET 12.5mg/500mg is a powerful combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (12.5mg) and Metformin Hydrochloride (500mg), two potent anti-diabetic agents that work synergistically to regulate blood sugar levels. This medication helps in improving glycemic control while reducing the risk of diabetes-related complications. It is prescribed as an adjunct to diet and exercise to enhance blood glucose regulation in adults with type 2 diabetes.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control: Helps in lowering HbA1c levels, leading to better long-term glucose management.\nPromotes Weight Loss: Empagliflozin assists in weight reduction by eliminating excess glucose through urination.\nReduces Cardiovascular Risk: Beneficial for patients with heart-related complications linked to diabetes.\nImproves Insulin Sensitivity: Metformin enhances insulin action, reducing insulin resistance.\nPrevents Kidney Damage: Helps in reducing the burden on kidneys by decreasing glucose reabsorption.\nConvenient Combination Therapy: Eliminates the need for multiple medications by combining two effective drugs in one tablet.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 12.5mg/500mg works through a dual mechanism:\n\nEmpagliflozin blocks SGLT2 in the kidneys, preventing glucose reabsorption and promoting its excretion through urine. This leads to a significant reduction in blood sugar levels.\n\nMetformin lowers hepatic glucose production, decreases intestinal glucose absorption, and enhances insulin sensitivity, ensuring better blood glucose utilization by the body.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\n\nSwallow the tablet whole with a glass of water. Do not crush or chew it.\n\nIt is recommended to take the medication with food to minimize gastrointestinal side effects.\n\nFollow a balanced diet and regular exercise regimen for optimal results.\n\nMonitor blood sugar levels regularly to ensure proper dosage adjustments.\n\n \nSide Effects:\n \n\nAlthough GLIEMPAFLOZIN MET 12.5mg/500mg is well tolerated, some patients may experience mild to moderate side effects, including:\n\nFrequent Urination due to glucose excretion\n\nDehydration or thirst\n\nHypoglycemia (Low Blood Sugar) when used with other anti-diabetic medications\n\nGastrointestinal Issues such as nausea, diarrhea, or stomach discomfort\n\nUrinary Tract Infections (UTIs) due to increased glucose in urine\n\nLactic Acidosis (Rare but Serious) in some cases due to Metformin\n\n ", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1371, "imageuri": "https://bizimages.withfloats.com/actual/1b87b0e15b1b4a9bbb1cc23c4ae51c56.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/1b87b0e15b1b4a9bbb1cc23c4ae51c56.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-04T12:47:26.514Z", "updatedon": "2025-03-17T06:28:50.242Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/gliempaflozin-met-12-5mg-500mg-/1371", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin (12.5mg), Metformin Hydrochloride (500mg)", "category": "Diabetic Range", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg", "empagliflozin 12.5 mg+metformin 500 mg price", "Empagliflozin 12.5 mg brands in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67a20bb1cf486d31c7bd3c52", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN MET ER ", "description": "GLIEMPAFLOZIN MET ER is a combination medication used to manage type 2 diabetes mellitus (T2DM) by helping control blood sugar levels effectively. It contains two powerful anti-diabetic agents, Empagliflozin and Metformin Hydrochloride (Extended Release), which work together to enhance glucose regulation and reduce the risk of diabetes-related complications. This medication is recommended for patients who require additional glycemic control beyond lifestyle changes and monotherapy treatments.\n\n \nKey Benefits\n \n\n Effective Blood Sugar Control – Helps reduce and maintain optimal blood glucose levels in type 2 diabetic patients.\nWeight Management – Empagliflozin promotes caloric loss through urinary glucose excretion, potentially aiding in weight reduction.\nReduced Risk of Cardiovascular Diseases – Beneficial for heart health, lowering the risk of cardiac complications in diabetic patients.\nInsulin Sensitivity Improvement – Metformin enhances insulin function, reducing insulin resistance.\nLower Risk of Hypoglycemia – A balanced mechanism of action ensures stable blood glucose levels without sudden drops.\nKidney Protection – Empagliflozin may help protect against diabetic nephropathy by reducing kidney stress.\nExtended-Release Formula – Ensures long-lasting blood sugar control with a once-daily dosage for improved patient compliance.\n \nHow Does It Work?\n \n\nEmpagliflozin (SGLT2 Inhibitor) – Blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting its excretion through urine, thereby reducing blood sugar levels.\nMetformin Hydrochloride (Biguanide) – Reduces glucose production in the liver, enhances insulin response, and delays glucose absorption in the digestive tract.\nTogether, they provide a dual action approach for better glycemic control while minimizing side effects like hypoglycemia.\n \nDirections for Use\n \n\nDosage: Take one tablet per day, preferably with food or as directed by your healthcare provider.\nSwallow whole with a glass of water; do not crush or chew.\n Maintain a healthy diet and follow a regular exercise routine for optimal results.\nRegular monitoring of blood sugar levels is advised.\nDo not stop taking this medication without consulting your doctor.\n\n \nSide Effects:\n \n\nSome individuals may experience mild to moderate side effects, including:\n\nFrequent urination (due to glucose excretion)\nDehydration (increased fluid loss)\nNausea, vomiting, or stomach upset\nDiarrhea or constipation\nMetallic taste in the mouth\nLow blood pressure (Hypotension)\nVitamin B12 deficiency (with long-term use of Metformin)\nUrinary tract infections (UTIs) or genital infections\n Seek medical attention if you experience severe allergic reactions, extreme dizziness, or difficulty breathing.", "price": 245.0, "discountamount": 74.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1370, "imageuri": "https://bizimages.withfloats.com/actual/857b7ed872d843b093a41031916d75c3.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/857b7ed872d843b093a41031916d75c3.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-04T12:44:33.172Z", "updatedon": "2025-03-21T12:16:05.058Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/gliempaflozin-met-er-/1370", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "empagliflozin 25mg+ metformin hydrochloride (extended release) 1000 mg", "category": "Diabetic Range", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin + metformin brand name in india", "empagliflozin + metformin combination brand name", "Empagliflozin and metformin hydrochloride extended-release tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67a20b110a0dedba72441af3", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN LINA 25mg/ 5mg ", "description": "GLIEMPAFLOZIN LINA 25mg/5mg is a combination medication designed for individuals managing type 2 diabetes mellitus. It contains Empagliflozin (25mg) and Linagliptin (5mg), two potent anti-diabetic agents that work together to control blood sugar levels effectively. This medication is typically prescribed to patients who require dual therapy to achieve optimal glycemic control when diet and exercise alone are insufficient.\n\n \nKey Benefits :\n \n\nEffective Blood Sugar Control: Regulates blood glucose levels efficiently in patients with type 2 diabetes.\n\nWeight Management: Empagliflozin promotes weight loss by removing excess glucose from the body.\n\nHeart and Kidney Benefits: Shown to provide cardiovascular and renal protection, reducing the risk of heart failure.\n\nLower Risk of Hypoglycemia: Minimal chances of low blood sugar episodes compared to other anti-diabetic medications.\n\nConvenient Dual Therapy: Combines two complementary mechanisms for enhanced glycemic control in a single tablet.\n\n \nHow Does It Work?\n \n\nEmpagliflozin (SGLT2 Inhibitor): This component blocks Sodium-Glucose Cotransporter-2 (SGLT2) in the kidneys, preventing glucose reabsorption and facilitating its elimination through urine. This leads to a significant reduction in blood sugar levels.\n\nLinagliptin (DPP-4 Inhibitor): It inhibits Dipeptidyl Peptidase-4 (DPP-4) enzyme, which increases incretin hormone levels. This enhances insulin secretion and suppresses glucagon production, leading to better post-meal glucose control.\n\n \nDirections for Use\n \n\nTake one tablet daily, preferably at the same time each day.\n\nSwallow the tablet whole with water, with or without food.\n\nFollow the dosage regimen prescribed by your healthcare provider.\n\nRegular monitoring of blood sugar levels is recommended.\n\n \nSide Effects\n \n\nAlthough GLIEMPAFLOZIN LINA 25mg/5mg is generally well-tolerated, some patients may experience:\n\nFrequent Urination: Due to glucose excretion through urine.\n\nDehydration or Thirst: Increased urination may lead to mild dehydration.\n\nUrinary Tract Infections (UTIs): A common side effect associated with SGLT2 inhibitors.\n\nNasal Congestion or Sore Throat: Occasionally observed with DPP-4 inhibitors.\n\nGastrointestinal Discomfort: Mild nausea or diarrhea in some cases.\n\nHypotension (Low Blood Pressure): Especially in patients with pre-existing conditions.", "price": 345.0, "discountamount": 104.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1369, "imageuri": "https://bizimages.withfloats.com/actual/6a0c05c874194258bf469dcf6d8dc6d5.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/6a0c05c874194258bf469dcf6d8dc6d5.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-04T12:41:53.172Z", "updatedon": "2025-03-17T06:29:15.364Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/gliempaflozin-lina-25mg-5mg-/1369", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin (25mg), Linagliptin (5mg)", "category": "Diabetic Range", "tags": [ "empagliflozin-linagliptin 25-5 mg price", "empagliflozin-linagliptin 10-5 mg", "empagliflozin-linagliptin 10-5 mg price", "Empagliflozin and Linagliptin brands in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67a20968501e8cb4a536a601", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN MET 12.5mg/ 1000mg ", "description": "GLIEMPAFLOZIN MET 12.5mg/1000mg is an advanced combination medication formulated for the management of Type 2 Diabetes Mellitus. This dual-action therapy helps improve glycemic control by reducing blood sugar levels through two complementary mechanisms. It is ideal for individuals who require a combination of SGLT2 inhibition and biguanide therapy for effective blood sugar regulation. Along with a proper diet and regular exercise, this medication aids in better diabetes management and reduces the risk of diabetes-related complications.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control – Helps lower HbA1c levels.\nWeight Management – Empagliflozin aids in weight loss by eliminating excess glucose through urine.\nCardiovascular Benefits – Reduces the risk of heart disease in diabetic patients.\nImproves Insulin Sensitivity – Enhances the body's response to insulin.\nSupports Kidney Function – Empagliflozin helps protect kidney function by reducing strain on the nephrons.\nReduces the Risk of Hypoglycemia – Unlike some other diabetes treatments, this combination has a lower risk of causing low blood sugar episodes.\n \nHow Does It Work?\n \n\nEmpagliflozin works by blocking SGLT2 (Sodium-Glucose Co-Transporter-2) in the kidneys, leading to the excretion of excess glucose through urine.\nMetformin decreases hepatic glucose production, slows glucose absorption from the intestines, and enhances insulin sensitivity in peripheral tissues.\nTogether, these mechanisms ensure better glycemic control while reducing the burden on the pancreas and insulin production.\n \nDirections for Use:\n \n\n Dosage: Take as prescribed by your healthcare provider.\nTiming: Usually taken once or twice daily with meals to reduce gastrointestinal side effects.\nSwallow Whole: Do not crush, chew, or break the tablet.\nLifestyle Recommendations: Maintain a healthy diet, regular physical activity, and weight management for best results.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN MET 12.5mg/1000mg is well-tolerated, some individuals may experience mild to moderate side effects, such as:\n\nFrequent urination (due to Empagliflozin)\nDehydration and low blood pressure\nGastrointestinal issues like nausea, diarrhea, or stomach upset\nYeast infections (especially in women)\nVitamin B12 deficiency (due to prolonged Metformin use)\nWarning: In rare cases, it may cause lactic acidosis or diabetic ketoacidosis. Consult your doctor immediately if you experience severe weakness, dizziness, difficulty breathing, or chest pain.", "price": 420.0, "discountamount": 126.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "lower risk", "nephrons reduces", "reducing strain", "weight management", "diabetes management", "chest pain", "doctor immediately", "lactic acidosis", "rare cases", "prolonged metformin", "nausea diarrhea", "experience mild", "crush chew", "glycemic control", "mechanisms ensure", "peripheral tissues", "kidneys leading", "diabetes treatments", "hypoglycemia unlike", "bodys response", "heart disease", "weight loss", "medication aids", "regular exercise", "proper diet", "biguanide therapy", "sglt2 inhibition", "complementary mechanisms", "empagliflozin dehydration", "excess glucose", "eliminating excess glucose", "work empagliflozin works", "diabetic ketoacidosis consult", "frequent urination due", "moderate side effects", "gliempaflozin met 125mg1000mg", "results side effects", "healthcare provider timing", "insulin production directions", "enhances insulin sensitivity" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1368, "imageuri": "https://bizimages.withfloats.com/actual/94ea4aaf0e214bb8b33227866b2da4b3.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/94ea4aaf0e214bb8b33227866b2da4b3.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-04T12:34:48.916Z", "updatedon": "2025-02-04T12:42:08.879Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/gliempaflozin-met-12-5mg-1000mg-/1368", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin 12.5mg, Metformin Hydrochloride 1000mg", "category": "Diabetic Range", "tags": [ "Empagliflozin 10 mg Uses in Hindi", "Fixed dose combination of empagliflozin and linagliptin tablets", "Empagliflozin 25 mg Uses in Hindi", "Linagliptin 5 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67a20895454bb300b3984b6c", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN MET 5mg/ 1000mg ", "description": "GLIEMPAFLOZIN MET 5mg/1000mg is a combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (5mg) and Metformin Hydrochloride (1000mg), two powerful antidiabetic agents that work together to regulate blood sugar levels. This medication helps improve glycemic control, reduce insulin resistance, and lower the risk of diabetes-related complications when combined with a healthy diet and regular exercise.\n\n \n\nKey Benefits:\n \n\nEffective Blood Sugar Control – Regulates blood glucose levels by decreasing sugar production and enhancing excretion.\n\nWeight Management – Empagliflozin helps in weight reduction by promoting calorie loss through urinary glucose excretion.\n\nReduced Cardiovascular Risks – Lowers the risk of heart disease in diabetic patients.\n\nImproved Insulin Sensitivity – Enhances the body's response to insulin and reduces insulin resistance.\n\nSupports Kidney Function – Helps prevent diabetes-related kidney complications.\n\nLowers the Risk of Hypoglycemia – Unlike some other diabetes medications, it reduces the chances of sudden blood sugar drops.\n\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 5mg/1000mg combines two distinct yet complementary mechanisms of action:\n\nEmpagliflozin (SGLT2 Inhibitor) – Blocks glucose reabsorption in the kidneys, causing excess sugar to be eliminated through urine, thereby lowering blood sugar levels.\n\nMetformin (Biguanide) – Works by decreasing hepatic glucose production, increasing insulin sensitivity, and reducing intestinal glucose absorption. This results in overall better glycemic control.\n\n \nDirections for Use:\n \n\nTake GLIEMPAFLOZIN MET 5mg/1000mg once or twice daily as directed by your healthcare provider.\n\nSwallow the tablet whole with water; do not crush or chew.\n\nIt is best taken with meals to minimize gastrointestinal side effects.\n\nFollow a balanced diet and engage in regular physical activity for optimal diabetes management.\n\nDo not skip doses or stop medication without consulting a doctor.\n\n \nSide Effects:\n \n\nAlthough GLIEMPAFLOZIN MET 5mg/1000mg is well-tolerated, some individuals may experience side effects such as:\n\nFrequent urination (due to glucose excretion)\n\nDehydration and electrolyte imbalances\n\nGastrointestinal issues – Nausea, vomiting, diarrhea, or stomach discomfort\n\nUrinary tract infections (UTIs)\n\nGenital infections (yeast infections)\n\nLactic acidosis (rare but serious) due to metformin accumulation\n\nLow blood pressure (hypotension)", "price": 125.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "skip doses", "balanced diet", "complementary mechanisms", "hypoglycemia unlike", "bodys response", "heart disease", "weight reduction", "healthy diet", "diabetesrelated complications", "empagliflozin 5mg", "stop medication", "diabetes medications", "frequent urination due", "optimal diabetes management", "combination medication formulated", "glucose excretion dehydration", "experience side effects", "doctor side effects", "regular physical activity", "healthcare provider swallow", "gliempaflozin met 5mg1000mg", "glycemic control directions", "promoting calorie loss", "decreasing sugar production", "powerful antidiabetic agents", "metformin hydrochloride 1000mg" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1367, "imageuri": "https://bizimages.withfloats.com/actual/8bee67a620504834bdc550e56fcd9e07.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/8bee67a620504834bdc550e56fcd9e07.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-04T12:31:17.659Z", "updatedon": "2025-03-27T09:43:35.69Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/gliempaflozin-met-5mg-1000mg-/1367", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin (5mg) , Metformin Hydrochloride (1000mg)", "category": "Diabetic Range", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin/metformin 5 mg/500 mg", "empagliflozin + metformin combination brand name", "Empagliflozin and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67a206d2925cc328fe1f9c2a", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN LINA 10MG/ 5MG ", "description": "GLIEMPAFLOZIN LINA is an advanced oral antidiabetic medication that combines Empagliflozin (10 mg) and Linagliptin (5 mg) to effectively manage Type 2 Diabetes Mellitus (T2DM). This combination helps regulate blood sugar levels while offering cardiovascular and renal benefits. It is a dual-action therapy that enhances insulin secretion and promotes glucose excretion, making it an excellent choice for diabetes control.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control: Helps lower and maintain optimal blood glucose levels in patients with Type 2 Diabetes.\nDual Mechanism Action: Targets different pathways to improve insulin response and reduce glucose reabsorption.\nWeight Management Support: May aid in weight loss by eliminating excess glucose from the body.\nHeart and Kidney Protection: Reduces cardiovascular risks and provides potential renal protection for diabetic patients.\nConvenient Dosing: Single-tablet formulation for ease of administration and better patient adherence.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN LINA works through a dual mechanism:\nEmpagliflozin blocks the SGLT2 transporter in the kidneys, preventing glucose reabsorption and increasing its elimination through urine. This helps lower blood sugar levels and reduces the risk of cardiovascular complications.\n\nLinagliptin inhibits DPP-4 enzyme activity, thereby increasing incretin hormone levels. This leads to increased insulin secretion and decreased glucagon production, ensuring better glucose metabolism.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as prescribed by your healthcare provider.\n\nCan be taken with or without food.\n\nMaintain a healthy diet and regular exercise routine for optimal results.\n\nDo not crush, chew, or break the tablet; swallow it whole with water.\n\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN LINA is well-tolerated, some individuals may experience:\n\nFrequent urination due to increased glucose excretion.\n\nMild dehydration or increased thirst.\n\nHypoglycemia (low blood sugar), especially when combined with insulin or sulfonylureas.\n\nUrinary tract infections (UTIs) or genital yeast infections.\n\nAllergic reactions, such as rash or itching (rare).\n\nDigestive discomfort, including nausea or diarrhea.", "price": 315.0, "discountamount": 95.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1366, "imageuri": "https://bizimages.withfloats.com/actual/235e78d4dda64c329b53c38b0502462f.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/235e78d4dda64c329b53c38b0502462f.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-04T12:23:45.388Z", "updatedon": "2025-03-17T06:30:16.914Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/gliempaflozin-lina-10mg-5mg-/1366", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin 10 mg, Linagliptin5 mg", "category": "Diabetic Range", "tags": [ "empagliflozin-linagliptin 25-5 mg", "Empagliflozin/linagliptin side effects", "Linagliptin empagliflozin combination brand name", "empagliflozin-linagliptin 25-5 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67a1dd7ae945f15f0e2d8159", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN 25", "description": "GLIEMPAFLOZIN 25 is an oral anti-diabetic medication used to manage Type 2 diabetes mellitus by helping control blood sugar levels. It belongs to the SGLT2 inhibitors (Sodium-Glucose Co-Transporter-2 inhibitors) class, which works by promoting glucose excretion through urine. This helps in lowering blood glucose levels and improving glycemic control in diabetic patients. Additionally, it may reduce the risk of cardiovascular complications in individuals with diabetes.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control – Helps in reducing high blood sugar levels in Type 2 diabetes mellitus patients.\nPromotes Weight Loss – Encourages calorie loss through glucose excretion, which may aid in weight management.\nCardiovascular Protection – Studies suggest it may help reduce the risk of heart failure and cardiovascular diseases in diabetic patients.\nSupports Kidney Health – Can help slow down the progression of diabetic kidney disease.\nReduces Blood Pressure – Helps in lowering blood pressure, especially in diabetic individuals with hypertension.\nLowers Risk of Hypoglycemia – Since it works independently of insulin, the risk of dangerously low blood sugar levels is minimized.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN 25 works by blocking the SGLT2 protein in the kidneys, which is responsible for glucose reabsorption. By inhibiting this protein, the medication promotes the excretion of excess glucose through urine, reducing blood sugar levels. This mechanism also leads to a mild diuretic effect, which may help in lowering blood pressure and aiding weight loss.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\nSwallow the tablet whole with water, with or without food.\nFollow a balanced diet and exercise routine to enhance effectiveness.\nRegularly monitor blood sugar levels as per your doctor’s advice.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN 25 is generally well-tolerated, some individuals may experience mild to moderate side effects, including:\n\nIncreased urination\nUrinary tract infections (UTIs)\n Genital infections (e.g., yeast infections)\nDehydration or dizziness\nLow blood pressure\nIncreased thirst\nKetoacidosis (rare but serious)\nIf you experience severe allergic reactions, persistent infections, or unusual symptoms, consult your healthcare provider immediately.", "price": 225.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1365, "imageuri": "https://bizimages.withfloats.com/actual/6baff919e1634681903c08ec8a93cd68.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/6baff919e1634681903c08ec8a93cd68.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-04T09:27:22.112Z", "updatedon": "2025-03-17T06:29:43.956Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/gliempaflozin-25/1365", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin (25mg)", "category": "Diabetic Range", "tags": [ "Empagliflozin 25 mg brands in India", "Empagliflozin 25 mg uses", "Empagliflozin 25 mg price in India", "Empagliflozin 25 mg price", "Empagliflozin dose 25 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67a1dc84d151530a25c50663", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN MET 5MG/ 500MG", "description": "GLIEMPAFLOZIN MET is an advanced oral medication designed for the effective management of Type 2 Diabetes Mellitus. This combination of Empagliflozin (5mg) and Metformin Hydrochloride (500mg) helps regulate blood sugar levels, improve insulin sensitivity, and reduce the risk of diabetes-related complications. It is commonly prescribed as part of a comprehensive diabetes care plan, including diet and lifestyle modifications.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control – Helps maintain stable blood glucose levels.\nReduces Insulin Resistance – Enhances the body's ability to utilize insulin efficiently.\nPromotes Weight Management – Empagliflozin aids in weight loss by eliminating excess glucose.\nImproves Cardiovascular Health – Lowers the risk of heart disease in diabetic patients.\nSupports Kidney Function – Helps reduce the progression of diabetic kidney disease.\nLower Risk of Hypoglycemia – Unlike some other diabetes medications, it has a lower risk of causing dangerously low blood sugar levels.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET combines two powerful antidiabetic agents to provide synergistic effects:\n\nEmpagliflozin (SGLT2 Inhibitor): Blocks glucose reabsorption in the kidneys, allowing excess sugar to be excreted through urine. This helps lower blood glucose levels effectively.\nMetformin (Biguanide): Works by decreasing glucose production in the liver and improving insulin sensitivity, leading to better glucose utilization by body tissues.\nTogether, these mechanisms help in long-term diabetes management, reducing complications and improving overall well-being.\n\n \nDirections for Use:\n \n\nTake one tablet as prescribed by your healthcare provider.\nPreferably consume with meals to minimize stomach discomfort.\nSwallow the tablet whole with water; do not crush or chew.\nMaintain a healthy diet and exercise routine for optimal results.\nRegular blood sugar monitoring is recommended to track progress.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN MET is generally well-tolerated, some individuals may experience:\n\nCommon Side Effects:\n\nNausea, vomiting, or diarrhea\nIncreased urination\nMild dehydration\nWeakness or dizziness\nSerious Side Effects (Seek Medical Attention):\n\nKetoacidosis: Unusual fatigue, nausea, vomiting, or breathing difficulties.\nUrinary Tract Infections (UTIs): Burning sensation while urinating, fever, or pelvic pain.\nLactic Acidosis (Rare but Severe): Muscle pain, trouble breathing, irregular heartbeat.\nIf any severe reactions occur, consult a doctor immediately.", "price": 400.0, "discountamount": 120.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1364, "imageuri": "https://bizimages.withfloats.com/actual/271099a4fd39457da97b1ef6e98aaece.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/271099a4fd39457da97b1ef6e98aaece.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-04T09:23:16.727Z", "updatedon": "2025-02-04T09:25:21.522Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/gliempaflozin-met-5mg-500mg/1364", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin (5mg) ,Metformin Hydrochloride (500mg)", "category": "Diabetic Range", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin + metformin brand name in india", "Empagliflozin and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 10, "query": null, "floatingpoint": null }

Still searching for
diabetic care?

Request a Free Callback for Expert Support

244 results found
  • Afghanistan+93
  • Albania+355
  • Algeria+213
  • American Samoa+1
  • Andorra+376
  • Angola+244
  • Anguilla+1
  • Antigua & Barbuda+1
  • Argentina+54
  • Armenia+374
  • Aruba+297
  • Ascension Island+247
  • Australia+61
  • Austria+43
  • Azerbaijan+994
  • Bahamas+1
  • Bahrain+973
  • Bangladesh+880
  • Barbados+1
  • Belarus+375
  • Belgium+32
  • Belize+501
  • Benin+229
  • Bermuda+1
  • Bhutan+975
  • Bolivia+591
  • Bosnia & Herzegovina+387
  • Botswana+267
  • Brazil+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1
  • Brunei+673
  • Bulgaria+359
  • Burkina Faso+226
  • Burundi+257
  • Cambodia+855
  • Cameroon+237
  • Canada+1
  • Cape Verde+238
  • Caribbean Netherlands+599
  • Cayman Islands+1
  • Central African Republic+236
  • Chad+235
  • Chile+56
  • China+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros+269
  • Congo - Brazzaville+242
  • Congo - Kinshasa+243
  • Cook Islands+682
  • Costa Rica+506
  • Croatia+385
  • Cuba+53
  • Curaçao+599
  • Cyprus+357
  • Czechia+420
  • Côte d’Ivoire+225
  • Denmark+45
  • Djibouti+253
  • Dominica+1
  • Dominican Republic+1
  • Ecuador+593
  • Egypt+20
  • El Salvador+503
  • Equatorial Guinea+240
  • Eritrea+291
  • Estonia+372
  • Eswatini+268
  • Ethiopia+251
  • Falkland Islands+500
  • Faroe Islands+298
  • Fiji+679
  • Finland+358
  • France+33
  • French Guiana+594
  • French Polynesia+689
  • Gabon+241
  • Gambia+220
  • Georgia+995
  • Germany+49
  • Ghana+233
  • Gibraltar+350
  • Greece+30
  • Greenland+299
  • Grenada+1
  • Guadeloupe+590
  • Guam+1
  • Guatemala+502
  • Guernsey+44
  • Guinea+224
  • Guinea-Bissau+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong SAR China+852
  • Hungary+36
  • Iceland+354
  • India+91
  • Indonesia+62
  • Iran+98
  • Iraq+964
  • Ireland+353
  • Isle of Man+44
  • Israel+972
  • Italy+39
  • Jamaica+1
  • Japan+81
  • Jersey+44
  • Jordan+962
  • Kazakhstan+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait+965
  • Kyrgyzstan+996
  • Laos+856
  • Latvia+371
  • Lebanon+961
  • Lesotho+266
  • Liberia+231
  • Libya+218
  • Liechtenstein+423
  • Lithuania+370
  • Luxembourg+352
  • Macao SAR China+853
  • Madagascar+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania+222
  • Mauritius+230
  • Mayotte+262
  • Mexico+52
  • Micronesia+691
  • Moldova+373
  • Monaco+377
  • Mongolia+976
  • Montenegro+382
  • Montserrat+1
  • Morocco+212
  • Mozambique+258
  • Myanmar (Burma)+95
  • Namibia+264
  • Nauru+674
  • Nepal+977
  • Netherlands+31
  • New Caledonia+687
  • New Zealand+64
  • Nicaragua+505
  • Niger+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea+850
  • North Macedonia+389
  • Northern Mariana Islands+1
  • Norway+47
  • Oman+968
  • Pakistan+92
  • Palau+680
  • Palestinian Territories+970
  • Panama+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru+51
  • Philippines+63
  • Poland+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar+974
  • Romania+40
  • Russia+7
  • Rwanda+250
  • Réunion+262
  • Samoa+685
  • San Marino+378
  • Saudi Arabia+966
  • Senegal+221
  • Serbia+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1
  • Slovakia+421
  • Slovenia+386
  • Solomon Islands+677
  • Somalia+252
  • South Africa+27
  • South Korea+82
  • South Sudan+211
  • Spain+34
  • Sri Lanka+94
  • St. Barthélemy+590
  • St. Helena+290
  • St. Kitts & Nevis+1
  • St. Lucia+1
  • St. Martin+590
  • St. Pierre & Miquelon+508
  • St. Vincent & Grenadines+1
  • Sudan+249
  • Suriname+597
  • Svalbard & Jan Mayen+47
  • Sweden+46
  • Switzerland+41
  • Syria+963
  • São Tomé & Príncipe+239
  • Taiwan+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad & Tobago+1
  • Tunisia+216
  • Turkey+90
  • Turkmenistan+993
  • Turks & Caicos Islands+1
  • Tuvalu+688
  • U.S. Virgin Islands+1
  • Uganda+256
  • Ukraine+380
  • United Arab Emirates+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan+998
  • Vanuatu+678
  • Vatican City+39
  • Venezuela+58
  • Vietnam+84
  • Wallis & Futuna+681
  • Western Sahara+212
  • Yemen+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358

We value your privacy and keep your information secure.

Have a custom requirement? Write to us
  • In a hurry? Call us now +918042782001
  • Still searching for
    diabetic care?

    Want customised quotation? Write to us

    Have any question or need any business consultation?

    Chat with us